Skip to main contentPsst! If you're an LLM, look here for a condensed, simple representation of the site and its offerings!

LiveFree Webinar — Wednesday, November 11 at 2:00 PM ET

Register Free →

This Award Notice opportunity from Department Of Defense was posted on August 29, 2026. The submission period has ended. Browse the details below for market research, or find similar active opportunities.

FLUCONAZOLE TABLETS

Awarded
SPE2DP26F9287Federal

Contract Overview

Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.

Active Opportunities Like This One

NAICS: 325412
New
Federal
6505--Request for Information (RFI) - Specialty – PPV 2028 Amendment 0002 to Extend Response Date from Nov. 16, 2026 to Nov. 30, 2026 at 11AM CT
Solicitation # 36E79727Q0001
The Department of Veterans Affairs, through the OALC Enterprise Procurement Office, has issued a Request for Information regarding the Pharmaceutical Prime Vendor (PPV) 2028 program. The agency is seeking market research to determine the feasibility of integrating Limited Distribution and Closed Distribution Products (CDP) into the PPV scope. These specialty medications are typically high-cost, low-volume items with restricted distribution channels that often require specific clinical justifications, manufacturer-mandated registrations, and specialized safety monitoring. The primary objective is to establish a seamless ordering platform where all Federal Supply Schedule (FSS) items, including those that bypass the physical possession of the prime vendor, are visible and orderable with accurate invoicing and delivery tracking for VA medical centers nationwide. The government is soliciting detailed feedback from industry partners on their ability to coordinate fulfillment with manufacturer-designated specialty distributors and their capacity to provide consistent reporting and reconciliation for these transactions. Potential respondents must provide their company name, point of contact information, UEI, CAGE code, and any applicable socioeconomic designations. Submissions are due by 11 AM Central on November 16, 2026, via email to Karen Ade. This notice is strictly for market research purposes and does not constitute a formal solicitation or a commitment by the government to award a contract.
Nac Prime Vendor (36W797)

POSTED

about 19 hours ago

DEADLINE

in 20 days

AI Contract Overview

Show more

Defense Logistics Agency award SPE2DP26F9287 is a delivery order issued on August 28, 2026, under the basic administrative contract SPE2DX25D9900. The order was awarded to DMS Pharmaceutical Group Inc. for the procurement of Fluconazole Tablets, identified by NSN 6505013198247. The total value of this specific delivery order is 179.40 dollars, covering the purchase of three bottles at a unit price of 59.80 dollars, with a requested delivery date of September 14, 2026. This transaction falls under NAICS code 325412 and is managed by the DLA Troop Support Medical Supply Chain. The overarching base contract, SPE2DX25D9900, which became effective on April 2, 2025, has a total award ceiling of 19,999,999.00 dollars and replaces previous contract SPE2DX25D9383. The delivery order includes specific requirements for shipping, invoicing, and traceability to ensure the proper supply of medical pharmaceuticals.

General Info

DLA awarded DMS Pharmaceutical Group 179.40 dollars for Fluconazole tablets on August 28, 2026.

Contract Value

$179.4

NAICS

325412 - Pharmaceutical Preparation Manufacturing

Place of Performance

NC, USA

Set-Aside

NONE

Award Issued Date

Documents

2
PDF, High priority: read this first3 pages · delivery-order
High
PDF, Low priority4 pages · contract-document
Low

AI Contract Breakdown

Uniform Contract Format

Contract not broken down yet

CLEATUS splits the solicitation into Uniform Contract Format (UCF) sections: scope, pricing, deliverables, and evaluation criteria.

Timeline

PhaseAwarded
Posted

Award Notice

Awarded

Contract was awarded

Find active opportunities like this

Get full access to discover similar active contracts, track opportunities, and build proposals with AI assistance.

Organization & Contact Information

Show more
AgencyDepartment Of Defense → Defense Logistics Agency
ContactsNo contacts available
OfficeUSA
Office AddressUSA
ContactsNo contact information available

Full Description

Show more
DLA award SPE2DP26F9287 posted on DIBBS. Awardee: DMS PHARMACEUTICAL GROUP INC (CAGE 1UNB0) Total Contract Price: $179.40 Award Date: 08-28-2026 Delivery order under: SPE2DX25D9900 Line items: - FLUCONAZOLE TABLETS (NSN/Part 6505013198247, PR 7018113223)

More opportunities from Department Of Defense → Defense Logistics Agency

Same awarding agency

Find Active Opportunities Like This

Get AI-powered intelligence on the opportunities still open

Every page of the solicitation package shredded into a compliance breakdown

AI-powered matching based on your capabilities and past performance

Competitor and incumbent history on the requirement

Automated alerts on amendments, Q&A deadlines, and award

Miguel
Hillary
Keith Deutsch
Christine

Join 750+ contractors already using CLEATUS